Structure-activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties

被引:30
作者
Corte, James R. [1 ]
Fang, Tianan [1 ]
Pinto, Donald J. P. [1 ]
Han, Wei [1 ]
Hu, Zilun [1 ]
Jiang, Xiang-Jun [1 ]
Li, Yun-Long [1 ]
Gauuan, Jolicia F. [2 ]
Hadden, Mark [2 ]
Orton, Darren [2 ]
Rendina, Alan R. [1 ]
Luettgen, Joseph M. [1 ]
Wong, Pancras C. [1 ]
He, Kan [1 ]
Morin, Paul E. [1 ]
Chang, Chong-Hwan [1 ]
Cheney, Daniel L. [1 ]
Knabb, Robert M. [1 ]
Wexler, Ruth R. [1 ]
Lam, Patrick Y. S. [1 ]
机构
[1] Bristol Myers Squibb Res & Dev, Princeton, NJ 08543 USA
[2] Albany Mol Res Inc, Albany, NY 12212 USA
关键词
factor Xa; anthranilamide;
D O I
10.1016/j.bmcl.2008.03.092
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction of the phenyl piperidinone and phenyl pyridinone P4 moieties in the anthranilamide scaffold led to potent, selective, and orally bioavailable inhibitors of factor Xa. Anthranilamide 28 displayed comparable efficacy to apixaban in the rabbit arteriovenous-shunt (AV) thrombosis model. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2845 / 2849
页数:5
相关论文
共 24 条
[1]   Crystal structures of two potent nonamidine inhibitors bound to factor Xa [J].
Adler, M ;
Kochanny, MJ ;
Ye, B ;
Rumennik, G ;
Light, DR ;
Biancalana, S ;
Whitlow, M .
BIOCHEMISTRY, 2002, 41 (52) :15514-15523
[2]  
BASHA A, 1977, TETRAHEDRON LETT, P4171
[3]   New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin [J].
Bates, SM ;
Weitz, JI .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (08) :1017-1028
[4]  
Elg M, 1997, THROMB HAEMOSTASIS, V78, P1286
[5]   Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase [J].
Gould, WR ;
Cladera, E ;
Harris, MS ;
Zhang, EL ;
Narasimhan, L ;
Thorn, JM ;
Leadley, RJ .
BIOCHEMISTRY, 2005, 44 (26) :9280-9289
[6]   A general and efficient copper catalyst for the amidation of aryl halides [J].
Klapars, A ;
Huang, XH ;
Buchwald, SL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (25) :7421-7428
[7]   Exosite-driven substrate specificity and function in coagulation [J].
Krishnaswamy, S .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) :54-67
[8]  
Luettgen JM, 2006, BLOOD, V108, p112B
[9]   Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa [J].
Mederski, WWKR ;
Cezanne, B ;
van Amsterdam, C ;
Bühring, KU ;
Dorsch, D ;
Gleitz, J ;
März, J ;
Tsaklakidis, C .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (23) :5817-5822
[10]   Anthranilamide inhibitors of factor Xa [J].
Mendel, David ;
Marquart, Angela L. ;
Joseph, Sajan ;
Waid, Philip ;
Yee, Ying K. ;
Tebbe, Anne Louise ;
Ratz, Andrew M. ;
Herron, David K. ;
Goodson, Theodore ;
Masters, John J. ;
Franciskovich, Jeffry B. ;
Tinsley, Jennifer M. ;
Wiley, Michael R. ;
Weir, Leonard C. ;
Kyle, Jeffrey A. ;
Klimkowski, Valentine J. ;
Smith, Gerald F. ;
Towner, Richard D. ;
Froelich, Larry L. ;
Buben, John ;
Craft, Trelia J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (17) :4832-4836